Santagostino, E. Et Al. 2015. Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials. HAEMOPHILIA , vol.21, no.1 , 34-40.

Santagostino, E., Lentz, S. R., Misgav, M., Brand, B., Chowdary, P., Savic, A., ... Kilinc, Y.(2015). Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials. HAEMOPHILIA , vol.21, no.1, 34-40.

Santagostino, E. Et Al. "Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials," HAEMOPHILIA , vol.21, no.1, 34-40, 2015

Santagostino, E. Et Al. "Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials." HAEMOPHILIA , vol.21, no.1, pp.34-40, 2015

Santagostino, E. Et Al. (2015) . "Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials." HAEMOPHILIA , vol.21, no.1, pp.34-40.

@article{article, author={E. Santagostino Et Al. }, title={Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials}, journal={HAEMOPHILIA}, year=2015, pages={34-40} }